UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals

September 20, 2024

UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale was in Concord Biotech, worth Rs 192 crore at a 15% premium.

More To Explore

Tech View: Nifty forms hammer candle; rebound from 23,500 offers hope. How to trade on Thursday

The Nifty’s short-term trend remains weak, but a smart recovery near 23,500 levels suggests a potential upside bounce. A sustained move above 23,800 levels could

January 8, 2025

NSE expands colocation facility in Mumbai with 200 new racks

The NSE expanded its colocation facility in Mumbai, adding over 200 racks and planning to reach 1,500 racks by FY25. It aims to scale capacity

January 8, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003